CV Sciences Files 8-K on Shareholder Votes and Financials

TL;DR

CV Sciences filed an 8-K on June 7th regarding shareholder votes and financials.

AI Summary

CV Sciences, Inc. filed an 8-K on June 7, 2024, reporting on matters submitted to a vote of security holders and financial statements as of June 3, 2024. The filing details the company's corporate structure and historical name changes, including its former names CannaVEST Corp. and Foreclosure Solutions, Inc.

Why It Matters

This filing provides an update on corporate actions and financial reporting for CV Sciences, Inc., which is important for investors to track the company's governance and financial health.

Risk Assessment

Risk Level: low — This is a routine filing reporting on corporate actions and financial statements, not indicating any immediate operational or financial distress.

Key Players & Entities

• CV Sciences, Inc. (company) — Registrant
• CannaVEST Corp. (company) — Former company name
• Foreclosure Solutions, Inc. (company) — Former company name
• June 3, 2024 (date) — Date of earliest event reported
• June 7, 2024 (date) — Date of report

FAQ

Filing Documents

• cvsi-20240603.htm (8-K) — 56KB
• 0000950170-24-069998.txt ( ) — 155KB
• cvsi-20240603.xsd (EX-101.SCH) — 22KB
• cvsi-20240603_htm.xml (XML) — 4KB

07 Submission of Matters to a Vote of Security Holders

Item 5.07 Submission of Matters to a Vote of Security Holders. On June 3, 2024, the Company held the 2024 Annual Meeting in a virtual format. At the close of business on April 5, 2024, the record date for the 2024 Annual Meeting, there were 163,228,469 shares of common stock issued and outstanding, which constituted all of the outstanding capital stock of the Company. At the 2024 Annual Meeting, 86,682,380 of the 163,228,469 outstanding shares of common stock entitled to vote, or approximately 53.1%, were represented by proxy at the meeting, and, therefore, a quorum was present. The proposals voted on at the 2024 Annual Meeting are more fully described in Proxy Statement, which is incorporated herein by reference. The final voting results on the proposals presented for stockholder approval at the 2024 Annual Meeting were as follows: Proposal 1 - Election of Directors The Company's stockholders elected three directors, each to serve until the Company's next Annual Meeting of Stockholders or until his successor is duly elected and qualified, subject to prior death, resignation or removal, as set forth below: NAME FOR AGAINST ABSTAIN BROKER NON-VOTE Dr. Jamie Corroon 28,999,412 1,431,719 1,022,695 55,228,554 Joseph Dowling 26,074,685 4,514,235 864,906 55,228,554 Bill McCorkle 28,764,821 1,644,045 1,044,960 55,228,554 Proposal 2 - Ratification of Selection of Independent Registered Public Accounting Firm The Company's stockholders ratified Haskell & White LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024, as set forth below: FOR AGAINST ABSTAIN BROKER NON-VOTE 84,248,548 1,837,030 596,802 — Proposal 3 - Advisory Vote to Approve Named Executive Officer Compensation The Company's stockholders approved, on a non-binding advisory basis, the Company's named executive officer compensation, as set forth below: FOR AGAINST ABSTAIN BROKE

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits (d) Exhibits Exhibit Number Description 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 1

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CV SCIENCES, INC. Date: June 6, 2024 By: /s/ Joseph Dowling Joseph Dowling Chief Executive Officer 2

View Full Filing

View this 8-K filing on SEC EDGAR